Premixed Insulins (70/30, 50/50) Injectable Suppliers & Bulk Manufacturers
Available Forms: Vials, pens
Available Strengths: U-100
Reference Brands: Humulin, Novolin(US); Mixtard, Humulin, Insuman(EU)
Category: Diabetes
Premixed Insulins (70/30, 50/50) Injectable is available in Vials, pens and strengths such as U-100. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Premixed Insulins (70/30, 50/50) Injectable is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
| Technical Specifications & Supply Details | |
|---|---|
| Lead Time | 7 to 60 days (depending on batch size & schedule) |
| MOQ | As per manufacturer’s batch size |
| COA | Available with every batch |
| Regulatory Dossier / DMF | Available upon request |
| Export Documentation | FSC, COA, Manufacturing License, Product Permission |
| Standards | IP, BP, USP |
| Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Premixed Insulins (70/30, 50/50) Injectable can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
Product Description:
Premixed insulins (70/30, 50/50) are regulated in the EU and US as combination biological medicines. In the EU, brands like Mixtard and Humulin 70/30 are approved by EMA based on comprehensive dossiers demonstrating safety, efficacy, and manufacturing quality. In the US, the FDA has approved products like Humulin 70/30 and Novolin 70/30, supported by detailed clinical data and biosimilarity assessments, with ongoing pharmacovigilance. Both regions require robust regulatory dossiers for approval and post-marketing safety. For expert support with pharmaceutical dossiers and compliance, visit PharmaTradz, your trusted partner in regulatory solutions.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Related Products
Sotagliflozin
Strength:
200 mg, 40mg
Form: Tablets
Reference Brands: Inpefa (USA), Zynquista (EU)
View DetailsGlyburide
Strength:
1.25 mg, 2.5 mg, 5 mg
Form: Tablets
Reference Brands: Diabeta (USA), Micronase (USA), Glynase PresTab (USA)
View DetailsExenatide
Strength:
5mcg, 10mcg
Form: injection (prefilled syringe)
Reference Brands: Byetta (USA/EU)
View DetailsQuick Response Guaranteed | Verified Suppliers